1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Retinal Degeneration Global Clinical Trials Review, H2, 2015

Retinal Degeneration Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Retinal Degeneration Global Clinical Trials Review, H2, 2015" provides an overview of Retinal Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Retinal Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Retinal Degeneration Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Retinal Degeneration 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Retinal Degeneration to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Retinal Degeneration to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Retinal Degeneration 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Retinal Degeneration Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Santhera Pharmaceuticals Holding AG 32
Clinical Trial Overview of Santhera Pharmaceuticals Holding AG 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Oraya Therapeutics, Inc. 34
Clinical Trial Overview of Oraya Therapeutics, Inc. 34
NightstaRx Ltd 35
Clinical Trial Overview of NightstaRx Ltd 35
Inotek Pharmaceuticals Corporation 36
Clinical Trial Overview of Inotek Pharmaceuticals Corporation 36
China Shenghuo Pharmaceutical Holdings, Inc. 37
Clinical Trial Overview of China Shenghuo Pharmaceutical Holdings, Inc. 37
Applied Genetic Technologies Corporation 38
Clinical Trial Overview of Applied Genetic Technologies Corporation 38
AmpliPhi Biosciences Corporation 39
Clinical Trial Overview of AmpliPhi Biosciences Corporation 39
Allergan Plc 40
Clinical Trial Overview of Allergan Plc 40
Alberta Innovates- Health Solutions 41
Clinical Trial Overview of Alberta Innovates- Health Solutions 41
Clinical Trial Overview of Top Institutes / Government 42
Burgundy Association for Research in Ophthalmology 42
Clinical Trial Overview of Burgundy Association for Research in Ophthalmology 42
Catholic University of the Sacred Heart 43
Clinical Trial Overview of Catholic University of the Sacred Heart 43
Centre Hospitailer Universitarie d'Angers 44
Clinical Trial Overview of Centre Hospitailer Universitarie d'Angers 44
Cincinnati Eye Institute 45
Clinical Trial Overview of Cincinnati Eye Institute 45
National Eye Institute 46
Clinical Trial Overview of National Eye Institute 46
Northwestern University 47
Clinical Trial Overview of Northwestern University 47
Osaka University 48
Clinical Trial Overview of Osaka University 48
Royal Liverpool and Broadgreen University Hospitals NHS Trust 49
Clinical Trial Overview of Royal Liverpool and Broadgreen University Hospitals NHS Trust 49
Shahid Beheshti University of Medical Sciences 50
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 50
U.S. Department of Veterans Affairs 51
Clinical Trial Overview of U.S. Department of Veterans Affairs 51
Five Key Clinical Profiles 52
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 82

List of Tables
Retinal Degeneration Therapeutics, Global, Clinical Trials by Region, 2015* 7
Retinal Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Retinal Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Retinal Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Retinal Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Retinal Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Retinal Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Retinal Degeneration Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Retinal Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Retinal Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Retinal Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Retinal Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Retinal Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Retinal Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Retinal Degeneration Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Retinal Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Retinal Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Retinal Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Retinal Degeneration Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Retinal Degeneration Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Retinal Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Retinal Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Retinal Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Retinal Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Retinal Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Santhera Pharmaceuticals Holding AG, 2015* 32
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 33
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Oraya Therapeutics, Inc., 2015* 34
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by NightstaRx Ltd, 2015* 35
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Inotek Pharmaceuticals Corporation, 2015* 36
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by China Shenghuo Pharmaceutical Holdings, Inc., 2015* 37
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Applied Genetic Technologies Corporation, 2015* 38
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by AmpliPhi Biosciences Corporation, 2015* 39
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015* 40
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Innovates- Health Solutions, 2015* 41
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Burgundy Association for Research in Ophthalmology, 2015* 42
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Catholic University of the Sacred Heart, 2015* 43
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitailer Universitarie d'Angers, 2015* 44
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Eye Institute, 2015* 45
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 46
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 47
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015* 48
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Liverpool and Broadgreen University Hospitals NHS Trust, 2015* 49
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 50
Retinal Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2015* 51

List of Figures
Retinal Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Retinal Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Retinal Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Retinal Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Retinal Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Retinal Degeneration Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Retinal Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Retinal Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Retinal Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Retinal Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Retinal Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Retinal Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Retinal Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Retinal Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Retinal Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Retinal Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Retinal Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Retinal Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Retinal Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Retinal Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Retinal Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 80

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.